Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal Cancers-Reference-Cited by-同舟云学术

Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal Cancers

Author:

Lechner Melissa G.¹,Vyas Chirag M.²,Hamnvik Ole-Petter R.³,Alexander Erik K.²,Larsen P. Reed²,Choueiri Toni K.⁴,Angell Trevor E.²

Affiliation:

1. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

2. Thyroid Section, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

3. Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

4. Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

Reference19 articles.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Anaesthesia Related Implications and Complications in Cancer Patients;Complications of Cancer Therapy: Best Practices in Prevention and Management;2024